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ABSTRACT
BEVACIZUMAB EFFECT ON EXPRESSION OF COLLAGEN TYPE I AFTER
TRABECULECTOMY
(EXPERIMENTAL STUDY ON ORYCTOLAGUS CUNICULUS)
Shinta Arta Wiguna, Nurwasis, Evelyn Komaratih, Heryawati
Objective : to determine the effect of bevacizumab as an antifibrotic agent on collagen
density, collagen thickness and collagen type I after trabeculectomy in rabbit.
Materials and methods : Sixteen male New Zealand white rabbits divided by two groups, 8
rabbits in control group and 8 rabbits in treatment group. Control group underwent
trabeculectomy and injection of balanced salt solution. Treatment group underwent
trabeculectomy and subconjunctival injection of bevacizumab (1.25mg, 25mg/mL). They
were terminated on 14 postoperative days. Masson Trichrome were performed to evaluate
collagen collagen density, collagen thickness. Immunohistochemistry using a monoclonal
antibody to collagen type I was performed to evaluate collagen type I expression.
Results : This study showed the density of collagen fibers decreased and statistically
significant in the treatment group (p = 0.075, p <0.05), whereas the the thickness of collagen
fibers did not have a significant decrease in both groups (p = 0.323, p > 0.05). Expression of
type I collagen obtained a decrease in the treatment group compared to BSS group (p =
0.006, p <0.05).
Conclusion : Bevacizumab reduces bleb fibrosis by inhibition of angiogenesis and
accumulation of extracellular matrix. Postoperative subconjunctival injection of
bevacizumab may limiting scar tissue formation at the site of trabeculectomy by blocking
collagen synthesis.
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